Serum Growth Hormone Levels and the Response of Diabetic Retinopathy to Pituitary Ablation*

No abstract is available for this paper.

• Publication year

  1969

• Venue

  British medical journal

• Publication date

  1969-05-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.2.5653.346PMID 5768460PMCID PMC1983255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standard procedures for assessing hypersecretion or secretory capacity for human growth hormone, using the radioimmunoassay.

  1968cited by this paper
• Pituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation).

  1968cited by this paper
• Diabetic retinopathy. I. The assessment of severity and progress by comparison with a set of standard fundus photographs.

  1967cited by this paper
• Diabetic retinopathy

  1967cited by this paper
• The significance of endocrine activity in hypophysectomized diabetics.

  1966cited by this paper
• Hypophysectomy for the treatment of advanced diabetic retinopathy.

  1966cited by this paper
• Growth hormone in relation to diabetic retinopathy.

  1966cited by this paper
• Pituitary ablation for diabetic retinopathy.

  1965cited by this paper
• Immunoassay of Serum Growth Hormone in Acromegalic Patients

  1964cited by this paper
• The effect of hypophyseal stalk section on advancing diabetic retinopathy. Report of thirteen cases.

  1962cited by this paper
• Observations on the influence of adrenalectomy on diabetic retinopathy.

  1962cited by this paper
• The use of hypophysectomy in juvenile diabetes mellitus with vascular complications.

  1962cited by this paper
• Vascular complications of diabetes mellitus.

  1959cited by this paper
• On the Nature and Treatment of Diabetes

  1862cited by this paper

• The Role and Diagnostic Potential of Insulin-like Growth Factor 1 in Diabetic Retinopathy and Diabetic Macular Edema

  2025cites this paper
• Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management

  2024cites this paper
• IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

  2016cites this paper
• Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?

  2016cites this paper
• Effects of GH/IGF-I Axis on Retinal Vascular Morphology: Retinal Vascular Characteristics in a Clinical Setting with Severe IGF-I Deficiency

  2014cites this paper
• The isolation, characterisation and investigation into the in vitro behaviour of human ocular vascular endothelial cells

  2013cites this paper
• IGFBP-3 as a Regulator of the Growth-Hormone/Insulin-Like Growth Factor Pathway in Proliferative Retinopathies

  2012cites this paper
• Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells

  2011cites this paper
• Serum insulin-like growth factor-I in diabetic retinopathy

  2011cites this paper
• The role of liver-derived insulin-like growth factor-I.

  2009cites this paper
• Long-term insulin-dependent diabetes mellitus with secondary pituitary insufficiency and regression of retinopathy.

  2009cites this paper
• Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture.

  2008cites this paper
• Choroidal neovascularization in patient undergoing growth hormone treatment

  2008cites this paper
• Rodent Models of Oxygen-Induced Retinopathy

  2008cites this paper
• Chapter 21 – Ocular Angiogenesis

  2008cites this paper
• Medical treatment of diabetic retinopathy with somatostatin analogues

  2007cites this paper
• [Diabetic retinopathy and vasoinhibins].

  2007cites this paper
• Retinopathy of prematurity

  2007cites this paper
• Retinopathy of Prematurity: Molecular Mechanism of Disease

  2006cites this paper
• Potential future targets for treating ocular neovascularization.

  2006cites this paper
• Deterioration of Visual Acuity Associated with Growth Hormone Therapy in a Child with Extreme Short Stature and High Hypermetropia

  2006cites this paper
• The Growth Hormone Hypothesis - 2005 Revision

  2005cites this paper
• Pathogenesis of retinopathy of prematurity.

  2004cites this paper
• Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression.

  2004cites this paper
• Medical treatment of diabetic retinopathy

  2003cites this paper
• Pathogenesis of retinopathy of prematurity.

  2003cites this paper
• The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis

  2003cites this paper
• Ocular neovascularization: a valuable model system

  2003cites this paper
• Severe diabetic retinopathy: a rare complication of acromegaly

  2002cites this paper
• IGF-I is critical for normal vascularization of the human retina.

  2002cites this paper
• Review: Thirty-seven years with diabetic retinopathy

  2002cites this paper
• Therapeutic Potential of Insulin-Like Growth Factor-1 in Patients with Diabetes Mellitus

  2002cites this paper
• Octreotide Reduces Vitreous Hemorrhage and Loss of Visual Acuity Risk in Patients with High-Risk Proliferative Diabetic Retinopathy

  2001cites this paper
• Physical Growth and Retinopathy in Preterm Infants: Involvement of IGF-I and GH

  2001cites this paper
• The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathy.

  2001cites this paper
• Safety aspects of growth hormone replacement in adults.

  2001cites this paper
• Growth hormone receptor antagonists: discovery and potential uses.

  2001cites this paper
• The role of growth hormone in the pathogenesis of vascular complications of diabetes mellitus.

  2000cites this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cites this paper
• Reduced retinal vascularization in children with growth hormone deficiency.

  1999cites this paper
• Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

  1997cites this paper
• Proliferatif Diyabetik Retinopati Oluşumunda Büyüme Hormonunun (GH) Etkisi

  1995cites this paper
• Retinopathy of Prematurity

  1995cites this paper
• New hypoglycaemic agents.

  1994cites this paper
• Theoretische und klinische Grundlagen des Typ-I-Diabetes

  1992cites this paper
• Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: A pilot study

  1991cites this paper
• Growth hormone and the microvascular complications of diabetes.

  1990cites this paper
• Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility study.

  1990cites this paper
• Growth Factors and Diabetic Complications

  1990cites this paper
• Aspects of growth hormone control in diabetes.

  1990cites this paper
• The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus.

  1989cites this paper
• Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy.

  1989cites this paper
• Retinopathy of prematurity.

  1988cites this paper
• Rationale for inhibition of growth hormone secretion in the management of the diabetic patient.

  1986cites this paper
• Fate of insulin in the retina: an autoradiographic study.

  1983cites this paper
• 7 – Control of Cell Division in the Ocular Lens, Retina, and Vitreous Humor

  1982cites this paper
• 4 Diabetic retinopathy

  1977cites this paper
• Diabetic retinopathy.

  1977cites this paper
• Interstitial gamma irradiation by 198Au of the pituitary in diabetic retinopathy. Selective growth hormone blockade and ocular results.

  1977cites this paper
• Prolonged follow-up in diabetic retinopathy treated by sectioning the pituitary stalk.

  1977cites this paper
• [Ophthalmologic indications and results of stereo-GIHF in diabetic retinopathy. 2].

  1977cites this paper
• Growth hormone response to L-Dopa in diabetes mellitus

  1976cites this paper
• Levodopa-stimulated growth hormone secretion and diabetic retinopathy.

  1976cites this paper
• Effect of pituitary ultrasonic treatment on plasma human growth hormone levels in diabetic retinopathy and acromegaly

  1975cites this paper
• Diabetic Complications in a Patient with Coexisting Anterior Hypopituitarism

  1975cites this paper
• Hypophysectomy in Diabetic Retinopathy: The Relationship Between the Degree of Pituitary Ablation and Ocular Response

  1974cites this paper
• Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy.

  1974cites this paper
• Plasma growth hormone response to insulin-induced hypoglycemia in diabetes mellitus

  1974cites this paper
• Diabetes mellitus.

  1974cites this paper
• [Diabetic retinopathy and its treatment with light coagulation].

  1972cites this paper
• Interactions of Growth Hormone with other Hormones

  1972cites this paper
• Measurement of pituitary hormones: clinical applications. 3. Growth hormone.

  1972cites this paper
• Bragg peak proton beam irradiation of the pituitary gland for proliferative diabetic retinopathy.

  1971cites this paper
• Diabetic Retinopathy: New Vessels Arising from the Optic Disc: II. Response to Pituitary Ablation by Yttrium 90 Implant

  1971cites this paper
• Cutaneous capillary resistance and retinal haemorrhage in diabetes

  1971cites this paper
• Treatment of diabetic retinopathy: pituitary ablation and retinal photocoagulation.

  1971cites this paper
• Effect of Pituitary Ablation on Diabetic Retinopathy Studied by Fluorescence Angiography

  1970cites this paper
• Long-term Effects of Transsphenoidal Hypophysectomy on Growth Hormone, Renal Function and Eyeground in Patients With Diabetic Retinopathy

  1970cites this paper
• Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy.

  1970cites this paper
• Human pituitary disease.

  1970cites this paper
• Diabetic retinopathy

  1967cites this paper